| 标题 |
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:Zi-Ming Li; Xiao-Rong Dong; Yan Yu; Wen-Xiu Yao; Yong-Zhong Luo; et al 出版日期:2026-10-26 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)